The Population Health Research Institute (PHRI) is Canada’s premiere global health research institute and a world leader in large clinical trials and population studies. Originally formed with a focus on cardiovascular disease (CVD) and diabetes, PHRI’s research areas have broadened to include population genomics, perioperative medicine, stroke, thrombosis, CV surgery, renal, obesity, childhood obesity, bone and trauma and implementation science.
Over the years, the PHRI has developed unparalleled expertise in epidemiology, population health and clinical trials. Examining biological and genetic determinants of health, as well as social, environmental and policy factors, the research focuses on the prevention of cardiovascular disease, diabetes and other common conditions. PHRI’s capacity to conduct several international studies concurrently, with tens of thousands of participants in each, is a capability very few organizations in the world can match. To date, PHRI studies have enrolled almost 1,000,000 participants worldwide.
A core strength of the PHRI is the multidisciplinary team of world-class scientists and research support teams. The environment promotes collaboration and a multifaceted approach which allows researchers to capitalize on the wealth of collective knowledge as they each bring areas of expertise to a single study.
Dr. Salim Yusuf is the Executive Director of PHRI with Dr. Hertzel Gerstein as the Deputy Director. PHRI has three Associate Directors responsible for scientific leadership who are: Dr. Sonia Anand, Dr. Stuart Connolly and Dr. Koon Teo. Janette Panhuis is the Chief Operating Officer responsible for operations. For more information, visit Governance Management.
To conduct trans-disciplinary research to improve major health outcomes in common and neglected conditions affecting Canadians and populations across the world.